Alopecia areata investigational assessment guidelines-Part II

摘要: Alopecia areata is an immunologically mediated disease characterized by extreme variability not only in the time of initial onset hair loss but duration, extent and pattern during any given episode active loss. These variables, as well unpredictable nature spontaneous regrowth lack a uniform response to various therapies, has made clinical trials alopecia difficult plan implement. In fact, there are currently no drugs FDA-approved specifically for indication areata. To help facilitate well-controlled areata, this National Areata Foundation (NAAF) sponsored subgroup investigators/clinicians experienced and/or care patients with outlined some general principles potential endpoints studies areata.Theseguidelines buildontheAlopeciaAreata